Page last updated: 2024-10-29

amrinone and Hyponatremia

amrinone has been researched along with Hyponatremia in 1 studies

Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.

Hyponatremia: Deficiency of sodium in the blood; salt depletion. (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"To determine the effects of vasodilator and inotropic therapy on hyponatremia in patients with severe heart failure, we measured serum sodium concentration before and after treatment with captopril (70 patients), hydralazine (42 patients), prazosin (22 patients), and amrinone (19 patients), while diuretic dosages were kept constant."3.67Correction of dilutional hyponatremia in severe chronic heart failure by converting-enzyme inhibition. ( Medina, N; Packer, M; Yushak, M, 1984)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Packer, M1
Medina, N1
Yushak, M1

Other Studies

1 other study available for amrinone and Hyponatremia

ArticleYear
Correction of dilutional hyponatremia in severe chronic heart failure by converting-enzyme inhibition.
    Annals of internal medicine, 1984, Volume: 100, Issue:6

    Topics: Adult; Aged; Aminopyridines; Amrinone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardioto

1984